| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.126 | 20.302 | 13.110 | 60.096 | 118.915 | 43.524 | 49.580 | 63.261 | 27.323 | 47.036 |
| Total Income - EUR | 6.825 | 20.401 | 13.128 | 60.383 | 120.399 | 44.792 | 49.758 | 66.347 | 30.344 | 47.294 |
| Total Expenses - EUR | 6.509 | 13.013 | 12.303 | 38.753 | 71.757 | 53.333 | 63.905 | 43.407 | 45.000 | 32.786 |
| Gross Profit/Loss - EUR | 316 | 7.388 | 825 | 21.630 | 48.642 | -8.541 | -14.147 | 22.939 | -14.657 | 14.508 |
| Net Profit/Loss - EUR | 111 | 6.788 | 431 | 19.818 | 45.085 | -9.762 | -15.637 | 21.438 | -14.935 | 14.047 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Dermaline Plus S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.310 | 26.775 | 28.352 | 22.674 | 63.305 | 37.272 | 830 | 16.217 | 3.606 | 1.861 |
| Current Assets | 5.562 | 9.244 | 31.419 | 102.987 | 115.792 | 78.262 | 56.641 | 80.646 | 63.752 | 87.657 |
| Inventories | 2.724 | 7.394 | 12.463 | 49.993 | 21.162 | 27.754 | 27.613 | 23.382 | 23.638 | 22.648 |
| Receivables | 1.162 | 1.052 | 8.458 | 18.597 | 10.997 | 8.417 | 2.114 | 27.492 | 12.099 | 4.881 |
| Cash | 1.676 | 799 | 10.498 | 34.397 | 83.633 | 42.091 | 26.914 | 29.772 | 28.015 | 60.129 |
| Shareholders Funds | 469 | 7.252 | 7.560 | 27.240 | 106.521 | 94.740 | 43.099 | 87.216 | 54.839 | 64.408 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 16.403 | 28.768 | 52.211 | 98.421 | 72.576 | 20.793 | 14.372 | 9.646 | 12.653 | 25.323 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4652
|
|||||||||
Comments - Dermaline Plus S.r.l.